In this case, Xstrahl 100 was used to treat a keloid scar on an earlobe that developed from an ear piercing.
Contact Us
In this case, Xstrahl 100 was used to treat a keloid scar on an earlobe that developed from an ear piercing.
Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
It can be difficult to treat non-melanoma skin cancer (NMSC) of the lower legs. The blood supply of the lower legs makes surgery challenging, and radiotherapy below the knee is controversial because of the fear of radiation-induced ulcers. In the study, "Lesion-based...
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
In the published study, "Split Course Superficial Radiotherapy in Scrotal Extramammary Paget’s Disease Allows Course Completion With Minimal Side Effects: A Case Study" by Gerald B. Fogarty, et al., the Xstrahl 300 system was used to treat Paget's disease to a...
Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://vimeo.com/718012693
Kilovoltage X-ray equipment maintains an integral role in the modern radiation therapy department for the treatment of non-melanoma skin cancer as well as other benign conditions and palliative applications. The use of low energy, therapeutic X-rays is often a...
George Wilson, PhD, Chief, Radiation Biology, William Beaumont Hospital Radiation Biology focuses on translational research in the areas of new treatments, combined modalities, and stem cell biology. The group has a heavy emphasis on incorporating molecular,...
Skin cancer is an increasingly common condition, particularly keratinocytic cancers like basal cell carcinoma and cutaneous squamous cell carcinoma. Surgery has been the standard treatment for these, but affects functional and/or cosmetic outcomes. Definitive...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |